Search

  • Sorting

  • Filter

Found 602 Results
Page 47 of 61

Forensics Made Easy


Mass spectrometry techniques are now commonplace for high throughput quantitation and screening, but also for research and discovery for food safety, forensics, environmental testing, and a host of other applications. The demands of these settings are different from traditional research, requiring MS systems which combine robust and reliable operation with straightforward day-to-day processing. The SCIEX X500R QTOF System has been developed specifically to meet these needs and is now helping to streamline the workflow of Zurich’s Institute of Forensic Medicine.

Tags: , , , , , , , , , , , , , , , , , , ,

August 29, 2017


Take on New Analytical Challenges with the TripleTOF 6600 Accurate Mass System


Stay ahead of the curve by using the most advanced and versatile high-resolution accurate mass technology. The TripleTOF® 6600 accurate mass QTOF system can help you to analyze your samples faster, without compromising between speed, resolution, and sensitivity. Explore the technological advances that give this system the performance edge.

Tags:

August 25, 2017


3 Workflows Designed to Accelerate Your Biologics Characterization


Biopharmaceutical development is booming and now an integral part of many pharmaceutical company pipelines. While these emerging biologics present exciting opportunities for the industry, their sophistication is challenging the limits of characterization at all stages of discovery and development.

Tags: , , , , , , , , , , , , , , , , , , , ,

August 24, 2017


Making Your Vitamin D Testing Dreams Come True


If you work in clinical diagnostics, you can probably confirm that most clinical laboratories have seen a 5 to 6-fold increase in 25-hydroxyvitamin D testing over the past decade, and volume is growing.  Furthermore, the Office of Inspector General (OIG) recently reported Vitamin D as one of the top five laboratory assays reimbursed by Medicare, accounting for 8.7 million laboratory tests and $337 million in reimbursement dollars.

Tags: , , , , , , , , , , , , , , , , , , ,


The Science Behind SelexION Differential Mobility Spectrometry Technology


Scientists and analysts across all fields of testing and research are increasingly challenged by complex samples requiring advanced analytical selectivity. And where LC-MS/MS sensitivity alone is not enough to meet the demands of modern day quantitative performance, Differential Ion Mobility Spectrometry (DMS) has proven to be a valuable addition.

Tags: , , , , , , , , , , , , , , , , , , , ,

August 22, 2017


Elimination of Interference using the SelexION Differential Mobility System for the Quantitation of Rituximab in a Dual Surrogate Peptide Approach


The quantitation of proteins using the surrogate peptide approach can complicate nominal mass Triple Quadrupole MRM measurements due to co-extracted interference when using non-selective extraction techniques such as pellet digestion. High resolution coupled with accurate mass filtering can mitigate such interference, as reported previously for the determination of rituximab using the TripleTOF 6600 (Protein Quant Approaches). However, an additional level of selectivity can often be achieved on nominal mass systems using the orthogonal gas-phase separation approach offered by the SelexION+® Differential Mobility System technology (DMS). Interfaced between the sampling orifice and ion source, the DMS separates ions based upon differences in their migration rates under alternating low and high field waveform amplitudes (Figure 1). Ion clustering in low fields and declustering in high fields amplifies the distinction in mobility of an ion, resulting in improved resolution from interfering species of differing molecular cross-section.1-4

Tags: , , , , , , , , , , , , , , , , , , , ,


Happy Birthday to SWATH Acquisition! 5 Years of Innovation


With its introduction at the HUPO World Congress in 2010 in Sydney Australia by Ruedi Aebersold, SWATH® Acquisition instantly intrigued scientists around the world. Here was a new technique with the potential to revolutionize the way proteomics studies were performed! Based on a data independent acquisition strategy using a SCIEX TripleTOF® 5600 system, SWATH was able to consistently identify and quantify at least as many peptides and proteins as other far more mature proteomics strategies on the market, but with quantitative accuracy and reproducibility rivaling gold standard MRM experiments! This solution was made broadly available to researchers with a full launch of SWATH Acquisition in the Analyst® TF 1.6 Software on the TripleTOF 5600+ System at ASMS 2012 in Vancouver (A Mine of Quantitative Proteomic Information.  Prof Dr. Ruedi Aebersold, Head of the Department of Biology, ETH Zurich).

Tags: , , , , , , , , , , , , , , , , , , , ,

August 21, 2017


5 Tips for Calibrating a QTOF Mass Spectrometer


Do you have questions about your mass spec? How about a workflow? Our community members are involved in active discussions and receive expert answers from customers like you, SCIEX scientists, and support specialists every week. One recent topic concerned the automatic calibration on TripleTOF® systems as answered by Dr. Christie Hunter whose focus is developing and testing innovative MS workflows for omics research through working collaboratively with the instrument, chemistry, and software research groups.

Tags: , , , , , , , , , , , , , , , , , , , ,

August 17, 2017


Enhancing In Vitro ADME Screening


LC-MS technology is helping contract research organization Cyprotex Discovery Ltd. perform bioanalysis of small molecules, peptides, and other pharmaceuticals, enabling quantification to be performed in complex matrices during in vitro ADME studies.

Tags: , , , , , , , , , , , , , , , , , , , ,

August 14, 2017


Host Cell Protein Analysis – Mass Spec’s Edge Over ELISA


The number of protein based drugs coming onto the market is at an all-time high, particularly those produced with a host cell system. With host cells come their own proteins. These host cell proteins (HCPs) constitute a major part of process-related impurities and can adversely affect drug safety, so it is critical that they are identified and quantified accurately.

Tags: , , , , , , , , , , , , , , , , , , , ,

August 11, 2017


Page 47 of 61

Pin It on Pinterest